G-CSF and HGF: combination of vasculogenesis and angiogenesis synergistically improves recovery in murine hind limb ischemia.

[1]  Xiaojun Du,et al.  Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction. , 2006, Cardiovascular research.

[2]  C. Nienaber,et al.  Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans , 2006, Nature Clinical Practice Cardiovascular Medicine.

[3]  I. Komuro,et al.  Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia. , 2006, Journal of the American College of Cardiology.

[4]  C. Nienaber,et al.  Preservation From Left Ventricular Remodeling by Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Use of Granulocyte-Colony–Stimulating Factor (FIRSTLINE-AMI) , 2005, Circulation.

[5]  Z. Han,et al.  Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. , 2005, Diabetes care.

[6]  M. Harmsen,et al.  Signaling factors in stem cell-mediated repair of infarcted myocardium. , 2005, Journal of molecular and cellular cardiology.

[7]  H. Figulla,et al.  Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction. , 2005, American heart journal.

[8]  H. Okano,et al.  Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. , 2004, Blood.

[9]  S. Ogawa,et al.  Powerful and controllable angiogenesis by using gene-modified cells expressing human hepatocyte growth factor and thymidine kinase. , 2004, Journal of the American College of Cardiology.

[10]  I. Komuro,et al.  Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  W. Schaper,et al.  Bone marrow-Derived Cells Do Not Incorporate Into the Adult Growing Vasculature , 2004, Circulation research.

[12]  K. Matsuo,et al.  Elevation of serum hepatocyte growth factor during granulocyte colony‐stimulating factor‐induced peripheral blood stem cell mobilization , 2004, British journal of haematology.

[13]  P. Carmeliet.  Angiogenesis in health and disease , 2003, Nature Medicine.

[14]  Philippe Leboulch,et al.  Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2 , 2003, Nature Medicine.

[15]  A. Engert,et al.  Clinical applications of granulocyte colony-stimulating factor: an update and summary , 2003, Annals of Hematology.

[16]  J. Isner,et al.  Endothelial progenitor cells for vascular regeneration. , 2002, Journal of hematotherapy & stem cell research.

[17]  M. Makuuchi,et al.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.

[18]  Federica Limana,et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Murohara,et al.  Augmentation of Postnatal Neovascularization With Autologous Bone Marrow Transplantation , 2001, Circulation.

[20]  O. Koç,et al.  Mesenchymal stem cells: heading into the clinic , 2001, Bone Marrow Transplantation.

[21]  M. Ogawa,et al.  CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor. , 2000, Blood.

[22]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[23]  J. Miyazaki,et al.  A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre‐mediated recombination , 2000, FEBS letters.

[24]  Y. Taniyama,et al.  Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. , 1999, Hypertension.

[25]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[26]  Thomas N. Sato,et al.  Increased vascularization in mice overexpressing angiopoietin-1. , 1998, Science.

[27]  A. Hekman,et al.  Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). , 1998, Experimental hematology.

[28]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[29]  J. Isner,et al.  Mouse model of angiogenesis. , 1998, The American journal of pathology.

[30]  P. Huang,et al.  Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.

[31]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[32]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[33]  Takayuki Asahara,et al.  Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb , 1996, The Lancet.

[34]  G. Michalopoulos,et al.  Mini-review the Many Faces of Hepatocyte Growth Factor: from Hepatopoiesis to Hematopoiesis Structural Properties of Hgf the Hgf Receptor , 1995 .

[35]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[36]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.